CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
about
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusNeurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signalingThe endocannabinoid system as an emerging target of pharmacotherapyGlutamatergic substrates of drug addiction and alcoholismEmerging roles for endocannabinoids in long-term synaptic plasticityFetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids SignalingTRPV1 Channel: A Potential Drug Target for Treating EpilepsyExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsControl of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptorsGenetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO modelEndocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learningEndocannabinoid-mediated synaptic plasticity and addiction-related behaviorRetrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineNeuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityDrug-induced hypothermia in stroke models: does it always protect?Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channelsEnhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modalityA review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium.Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionThe CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.Effects of endocannabinoid system modulation on cognitive and emotional behaviorUnwinding the molecular basis of interval and circadian timing.The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated ratsDopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.Endocannabinoid-dopamine interactions in striatal synaptic plasticity.The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.New insights on endocannabinoid transmission in psychomotor disorders.Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical AfferentsChronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdalaAn animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.
P2860
Q24597687-93F3743F-CB90-4008-B87E-810C3183E196Q24644749-0498F178-E495-45B9-8B32-1AAEECA79EE5Q24648473-8B797CDB-2340-4A31-9F4D-02C2FC7416C3Q24648924-E825A1E0-0D12-4DF4-8B3F-FDF6F859B713Q24672367-DCAC7F6A-D722-40CC-BBBF-D36BC043E4F9Q26777055-B4BD73CA-0002-4EBF-A7DA-3BF00D654D60Q26786478-2D5A48D5-83E3-4EBF-B842-21FEF8BD7C64Q28075692-D26E5FA9-D82C-46EF-8374-8AFB2A73E0F3Q28270337-88C2BD7F-9072-4473-8358-D85A641D142BQ28469322-C37D0761-1A64-48FD-9ECD-3F634A46259FQ28729172-3076F2D5-9CA9-404F-9A72-5CBC30B2F826Q28741238-6E121A51-ED61-4BDF-BE98-814FF8D30609Q29042501-B123558E-2328-4066-8545-304CD584A85FQ30415677-C43E42F5-95E0-40FB-8390-466C85E27E7DQ30417935-076BF131-F98A-4FD2-B364-5575A7EEA286Q30493991-25D8D96F-E197-4AB4-BB17-1767F4F59DD7Q30773183-75B71FBF-47BB-45A6-8E92-C6483FC12C98Q31032734-D95C4749-E835-4695-AE8E-BEC5A070A05CQ33751118-CCB21547-E89E-4886-A7BC-1DE1A1F7D21DQ33844760-AFEF9143-A2A9-47DA-8ED0-FEFEBFE32F2BQ33996977-0EFFB362-40CF-4D80-BF6D-BB9EC288D853Q34018061-9F4B2FFB-C029-4CF1-B5D6-D77DCE44E6A7Q34264449-A97E2542-CDA5-4EAC-8E7C-3B165656ABB4Q34660703-BF91191D-9217-4453-AE88-7F68C15F70C9Q34967151-796A9CDF-0A29-4722-9A38-40F3ABC82CB4Q35034305-58AF4939-AB06-4C8B-A93C-22E5D2E691FCQ35039222-9D290A1E-6917-4491-9085-D73FEC40AAD1Q35045001-B6FA79F0-2C5D-4C3A-AA49-1F187BED551BQ35209678-27FD203B-4CE5-4BDD-803D-5D7F1E1070ABQ35379888-EDA85488-A91D-4306-8834-FC835D1675ABQ35740152-1D504EDA-98C4-4058-8815-D18D3E8759CCQ35828317-05692B49-16B8-4214-9DBD-D31623A4B02EQ35898412-DF5FF350-6456-4AD3-AEB7-37A28C9B6286Q35989527-42C39A4A-2120-47DB-BA49-0697F484782AQ36074595-0E1B2109-6B4E-43AC-B40D-718E4F3E90A7Q36155898-160C5F80-91ED-48FD-90EC-50CD65CC2CAAQ36162473-B3B9413D-CB14-43C4-B71D-721C1CDEBB97Q36253945-51D02ACC-23D0-48D0-AB93-01FD3B3AC6B5Q36277731-48E22965-64D5-4AEB-86B6-E1EBBB3CDDD3Q36300113-57BC150E-B33B-4D96-BCAC-B97BC302CB57
P2860
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@ast
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@en
type
label
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@ast
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@en
prefLabel
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@ast
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@en
P921
P356
P1476
CB1 cannabinoid receptor inhib ...... in rat dorsolateral striatum.
@en
P2093
D M Lovinger
G Gerdeman
P304
P356
10.1152/JN.2001.85.1.468
P407
P577
2001-01-01T00:00:00Z